Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). Mehr anzeigen
Data show favorable safety and tolerability with dosing up to 800 mg for 10 daysPlans to initiate human challenge study in 2025 in norovirus-infected subjects BOTHELL, Wash., Jan. 08, 2025...
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuationsEnrollment to be extended due to low influenza infection among...
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30...
The Company’s antiviral candidate for seasonal and pandemic influenza shows in vitro activity against the avian influenza A PB2 protein, whereas current influenza vaccines offer no protection...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0613 | 2.99024390244 | 2.05 | 2.1749 | 1.88 | 29870 | 1.98480062 | CS |
| 4 | -0.5287 | -20.0265151515 | 2.64 | 3.26 | 1.88 | 92570 | 2.39342813 | CS |
| 12 | 0.3013 | 16.6464088398 | 1.81 | 3.26 | 1.65 | 47564 | 2.2825591 | CS |
| 26 | -0.1987 | -8.60173160173 | 2.31 | 3.26 | 1.6 | 30546 | 2.15739212 | CS |
| 52 | 0.6413 | 43.6258503401 | 1.47 | 3.26 | 1.325 | 27110 | 2.10346467 | CS |
| 156 | -4.0663 | -65.8232970733 | 6.1776 | 7.5588 | 1.325 | 86964 | 4.38933001 | CS |
| 260 | -6.4207 | -75.2543366151 | 8.532 | 49.2 | 1.325 | 2050865 | 18.87010914 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
